CD8+ T细胞在预后良好型急性髓系白血病中扩增干/祖细胞,而在预后不良型中不扩增
研究刻画了急性髓系白血病(AML)患者白血病干/祖细胞(LSPC)与配对CD8+ T细胞的分子特征。组蛋白脱乙酰化导致的表观遗传改变降低了骨髓浸润CD8+ T细胞中免疫相关基因的表达,而CD8+ T细胞中沉默的基因表达模式与预后改善显著相关。综合关联网络模型分析表明,CD8+ T细胞有助于LSPC的维持/扩增,尤其在预后良好型AML中;预后良好型AML中的CD8+ T细胞通过刺激白细胞介素(IL)-3等造血细胞因子的自分泌产生来诱导LSPC扩增;相反,侵袭性AML中的LSPC以干性/增殖相关通路更高激活为特征,并独立于骨髓CD8+ T细胞而发展。
要点
- CD8+ T细胞中沉默的基因表达模式与AML预后改善显著相关。
- 预后良好型AML中CD8+ T细胞通过刺激IL-3自分泌产生来诱导LSPC扩增。
- 侵袭性AML的LSPC干性/增殖通路激活更高,独立于骨髓CD8+ T细胞发展。
核心结论
- CD8+ T细胞在预后良好型AML中支持和扩增LSPC,而中间和不良风险型AML具有内在分子异常而独立发展。
研究设计与样本
- 研究刻画了AML患者白血病干/祖细胞(LSPC)与配对CD8+ T细胞的分子特征,并进行了综合关联网络建模。
主要发现
- 组蛋白脱乙酰化导致的表观遗传改变降低了骨髓浸润CD8+ T细胞中免疫相关基因的表达。
- CD8+ T细胞中沉默的基因表达模式与预后改善显著相关。
- 预后良好型AML中的CD8+ T细胞通过刺激IL-3等造血细胞因子的自分泌产生来诱导LSPC扩增。
- 侵袭性AML中的LSPC以干性/增殖相关通路更高激活为特征,并独立于骨髓CD8+ T细胞而发展。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
CD8+ T cell immunosurveillance is crucial in solid tumors and T cell dysfunction leads to tumor progression. In contrast, the role of CD8+ T cells in the control of leukemia is less clear. We characterized the molecular signature of leukemia stem/progenitor cells (LSPCs) and paired CD8+ T cells in patients with acute myeloid leukemia (AML). Epigenetic alterations via histone deacetylation reduced the expression of immune-related genes in bone marrow (BM)-infiltrating CD8+ T cells. Surprisingly, a silenced gene expression pattern in CD8+ T cells significantly correlated with an improved prognosis. To define interactions between CD8+ T cells and LSPCs, we performed comprehensive correlative network modeling. This analysis indicated that CD8+ T cells contribute to the maintenance/expansion of LSPCs, particularly in favorable risk AML. Functionally, CD8+ T cells in favorable AML induced the expansion of LSPCs by stimulating the autocrine production of important hematopoietic cytokines such as interleukin (IL)-3. In contrast, LSPCs in aggressive AML were characterized by a higher activation of stemness/proliferation-related pathways and develop independent of BM CD8+ T cells. Overall, our study indicates that CD8+ T cells support and expand LSPCs in favorable risk AML whereas intermediate and adverse risk AML possess the intrinsic molecular abnormalities to develop independently.
引用
- Radpour R, Riether C, Simillion C, et al. CD8+ T cells expand stem and progenitor cells in favorable but not adverse risk acute myeloid leukemia. Leukemia. 2019. PMID: 30877275. doi:10.1038/s41375-019-0441-9
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。